The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-planned feasibility and safety analyses of docetaxel/S-1 combination in a phase III study comparing docetaxel/S-1with S-1 alone as postoperative adjuvant chemotherapy for stage III gastric cancer (JACCRO GC-07).
 
Yoshihiro Kakeji
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Yasuhiro Kodera
Honoraria - Chugai Pharma; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb Japan (Inst); Chugai Pharma (Inst); Lilly Japan (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Kazuhiro Yoshida
No Relationships to Disclose
 
Mitsugu Kochi
No Relationships to Disclose
 
Masazumi Takahashi
No Relationships to Disclose
 
Takayuki Kii
No Relationships to Disclose
 
Atsushi Ishiguro
No Relationships to Disclose
 
Kiyoshi Ishigure
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Takanori Matsui
No Relationships to Disclose
 
Masahide Kaji
No Relationships to Disclose
 
Wataru Ichikawa
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Daiichi Sankyo; Merck Serono; Zeria Pharmaceutical
Research Funding - Taiho Pharmaceutical; Takeda
Travel, Accommodations, Expenses - Daiichi Sankyo
 
Takeshi Sano
No Relationships to Disclose
 
Masahiro Takeuchi
Honoraria - Takeda
Consulting or Advisory Role - AstraZeneca; Hisamitsu Pharmaceutical; Shionogi; Taiho Pharmaceutical
 
Masashi Fujii
Stock and Other Ownership Interests - Otsuka (I)
Consulting or Advisory Role - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Japan Clinical Cancer Research Organization
 
Toshifusa Nakajima
No Relationships to Disclose